MLN Connects for Thursday, July 22, 2021

COVID-19: EUA for Tocilizumab Monoclonal Antibody Product

MLN Connects newsletter for Thursday, July 22, 2021

View this edition as a: Webpage | PDF



* COVID-19: EUA for Tocilizumab Monoclonal Antibody Product

* Medicare Ground Ambulance Data Collection System FAQs

* Wound Debridement: Comparative Billing Report in July

* 3 Ways to Protect Your Medicare Enrollment Information

* Americans with Disabilities Act: 31st Anniversary

* Viral Hepatitis: Medicare Covers Preventive Services


* Polysomnography Services: Bill Correctly

Claims, Pricers, & Codes

* ICD-10-CM Diagnosis Code Files for FY 2022

MLN Matters® Articles

* Changes to the Laboratory National Coverage Determination (NCD) Edit Software for October 2021

* Implement Operating Rules - Phase III Electronic Remittance Advice (ERA) Electronic Funds Transfer (EFT): Committee on Operating Rules for Information Exchange (CORE) 360 Uniform Use of Claim Adjustment Reason Codes (CARC), Remittance Advice Remark Codes (RARC) and Claim Adjustment Group Code (CAGC) Rule - Update from Council for Affordable Quality Healthcare (CAQH) CORE

* October 2021 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files

* Quarterly Update to the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) Edits, Version 27.3, Effective October 1, 2021

* Section 50 in Chapter 30 of Publication (Pub.) 100-04 Manual Updates

* National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor (CAR) T-cell Therapy — Revised


* Critical Access Hospital — Revised

* Medicare Advance Written Notices of Noncoverage — Revised

* Rural Health Clinic — Revised


* Combating Medicare Parts C and D Fraud, Waste, and Abuse Web-Based Training — Revised

Last Updated: 07/22/2021